Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02062827
Title Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (M032-HSV-1)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

anaplastic astrocytoma

glioblastoma

gliosarcoma

Therapies

M032

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.